Recruitment of PVT1 Enhances YTHDC1-Mediated m6A Modification of IL-33 in Hyperoxia-Induced Lung Injury During Bronchopulmonary Dysplasia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recruitment of PVT1 Enhances YTHDC1-Mediated m6A Modification of IL-33 in Hyperoxia-Induced Lung Injury During Bronchopulmonary Dysplasia
Authors
Keywords
-
Journal
INFLAMMATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-02
DOI
10.1007/s10753-023-01923-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thrombin cleaves IL‐33 and modulates IL‐33‐activated allergic lung inflammation
- (2022) Yuying Huang et al. ALLERGY
- The effect of N6-methyladenosine (m6A) factors on the development of acute respiratory distress syndrome in the mouse model
- (2022) Liming Fei et al. Bioengineered
- MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
- (2022) Dong Cao et al. Journal of Bone Oncology
- CREB1 Transcriptionally Activates LTBR to Promote the NF-κB Pathway and Apoptosis in Lung Epithelial Cells
- (2022) Zhengyun Hu et al. Computational and Mathematical Methods in Medicine
- LncRNA SNHG6 accelerates hyperoxia-induced lung cell injury via regulating miR-335 to activate KLF5/NF-κB pathway
- (2022) Yan-Ni Meng et al. CYTOKINE
- The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1
- (2022) Wenyi Shen et al. Cancer Cell International
- IL‐33‐ST2 pathway regulates AECII transdifferentiation by targeting alveolar macrophage in a bronchopulmonary dysplasia mouse model
- (2022) Yue Zhu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interleukin-33 Induces Neutrophil Extracellular Trap (NET) Formation and Macrophage Necroptosis via Enhancing Oxidative Stress and Secretion of Proatherogenic Factors in Advanced Atherosclerosis
- (2022) Manoj Kumar Tembhre et al. Antioxidants
- The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity
- (2021) Jiadong Liu et al. NATURE
- Long non-coding RNA MALAT1 plays a protective role in bronchopulmonary dysplasia via the inhibition of apoptosis and interaction with the Keap1/Nrf2 signal pathway
- (2021) Min Zhang et al. Translational Pediatrics
- LncRNA PVT1 Regulates High Glucose-Induced Viability, Oxidative Stress, Fibrosis, and Inflammation in Diabetic Nephropathy via miR-325-3p/Snail1 Axis
- (2021) Baoyu Qin et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma
- (2021) Chang Gu et al. Frontiers in Cell and Developmental Biology
- Silencing of LncRNA-PVT1 ameliorates lipopolysaccharide-induced inflammation in THP-1-derived macrophages via inhibition of the p38 MAPK signaling pathway
- (2021) Shengcai Zheng et al. Annals of Palliative Medicine
- Quercetin regulates inflammation, oxidative stress, apoptosis, and mitochondrial structure and function in H9C2 cells by promoting PVT1 expression
- (2021) Fen Li et al. ACTA HISTOCHEMICA
- m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin
- (2021) Diefei Liang et al. Autophagy
- Insight Into the Roles of Non-coding RNA in Bronchopulmonary Dysplasia
- (2021) Yufeng Xi et al. Frontiers in Medicine
- TSLP and IL‐33 reciprocally promote each other's lung protein expression and ILC2 receptor expression to enhance innate type‐2 airway inflammation
- (2020) Shinji Toki et al. ALLERGY
- ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma
- (2020) Shuo Chen et al. Cancer Cell International
- IL-25/IL-33/TSLP contributes to idiopathic pulmonary fibrosis: Do alveolar epithelial cells and (myo)fibroblasts matter?
- (2020) Xuefeng Xu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Long non‐coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA‐146a
- (2020) Yujun Wang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- The potential role of RNA N6-methyladenosine in Cancer progression
- (2020) Tianyi Wang et al. Molecular Cancer
- IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia
- (2020) Rui Jin et al. Cell Death Discovery
- LncRNA PVT1 exacerbates the inflammation and cell‐barrier injury during asthma by regulating miR‐149
- (2020) Lianmei Ma et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Mechanism of lncRNA H19 in Regulating Pulmonary Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia Newborn Mice
- (2020) Lina Zhang et al. AMERICAN JOURNAL OF PERINATOLOGY
- Resveratrol alleviates alveolar epithelial cell injury induced by hyperoxia by reducing apoptosis and mitochondrial dysfunction
- (2020) Xiaodan Zhu et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- A Novel Diagnostic Marker for the Severity of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: Interleukin-33
- (2019) Ufuk Cakir et al. Pediatric Allergy Immunology and Pulmonology
- Protective effects of resveratrol on hyperoxia-induced lung injury in neonatal rats by alleviating apoptosis and ROS production
- (2019) Xiaodan Zhu et al. Journal of Maternal-Fetal & Neonatal Medicine
- Roles of TRPA1 and TRPV1 in cigarette smoke -induced airway epithelial cell injury model
- (2019) Muyun Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia
- (2019) Erica W. Mandell et al. CLINICS IN PERINATOLOGY
- Early Life Represents a Vulnerable Time Window for IL-33–Induced Peripheral Lung Pathology
- (2019) Li Y. Drake et al. JOURNAL OF IMMUNOLOGY
- Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1
- (2019) Yu Hu et al. MOLECULAR MEDICINE
- Methylation profiles of IL33 and CCL26 in bronchial epithelial cells are associated with asthma
- (2018) Miriam Larouche et al. Epigenomics
- Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation ( PVT1 ) as a novel regulator of the asthmatic phenotype in human airway smooth muscle
- (2017) Philip J. Austin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs
- (2017) Mansoor Syed et al. Nature Communications
- YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
- (2017) Ian A Roundtree et al. eLife
- IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice
- (2016) Thomas R. Shelite et al. PLoS Neglected Tropical Diseases
- Chronic Lung Disease in the Preterm Infant: Lessons Learned From Animal Models
- (2013) Anne Hilgendorff et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33-LacZ Gene Trap Reporter Strain
- (2012) M. Pichery et al. JOURNAL OF IMMUNOLOGY
- IFN-γ and IP-10 in tracheal aspirates from premature infants: Relationship with bronchopulmonary dysplasia
- (2012) Zubair H. Aghai et al. PEDIATRIC PULMONOLOGY
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
- (2012) E. Lefrancais et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils
- (2011) Ho Jeong Na et al. CYTOKINE
- Targeting Inflammation to Prevent Bronchopulmonary Dysplasia: Can New Insights Be Translated Into Therapies?
- (2011) C. J. Wright et al. PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started